Company Overview and News

313
RPT-Bank investors await U.S. stress test results for capital returns

50m reuters
NEW YORK, June 21 (Reuters) - U.S. investors expect banks and other financial institutions to announce large returns of capital to shareholders after the Federal Reserve publishes the first set of results from its annual “stress test” late Thursday.
HBANN HBANO HBANP C.WSA COF.WS GS.PRB GS.PRA RF FITBI CFIN ALLY.PRA GLSSP CIWV NTRS STI-A CIT JBK STI.WS.B STI.WS.A DFS COF-P CMA TFG GS.PRJ GS.PRI STI GS.PRD CGBBW GS.PRC FITB GS.PRN GS.PRK COF.PRG WFCNP COF.PRH RF.PRB CMA.WS RF.PRA NTRSP WFC.PRL COF.PRP WFC.PRJ CMPWW DFS.PRB COF-D WFC.PRT GS COF-C DFS.PRBCL C.WS.B COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP STI.PRE C.PRU WFC.PRY COF.PRC WFC.PRX COF.PRD WFC.PRW WFC.PRV COF.PRF C.PRS WFC WFC.WS C.PRL C GSC GS.PRICL C.PRJ C.PRK COF C.PRG GSJ C.PRC HBAN CFG ALLY C.PRPCL GJS

74
What's wrong with Asian stocks? Theories from Goldman and others

1h theedgemarkets
HONG KONG (June 22): It’s been a tumultuous two weeks for equity traders in Asia. And at some point, it just gets to be too much — strategists from Goldman Sachs Group Inc to Morgan Stanley have begun slashing their forecasts.
BDOUY GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA BDOUF GS GLSSP UBS UBS.PRDCL MS JBK GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI BDO MS.PRI GS.PRD MS.PRK GS.PRC GJS GS.PRN ULSGF GS.PRK

314
Bank investors await U.S. stress test results for capital returns

6h reuters
NEW YORK, June 21 (Reuters) - U.S. investors expect banks and other financial institutions to announce large returns of capital to shareholders after the Federal Reserve publishes the first set of results from its annual “stress test” late Thursday.
HBANN HBANO HBANP C.WSA COF.WS GS.PRB GS.PRA RF FITBI CFIN ALLY.PRA GLSSP CIWV NTRS STI-A CIT JBK STI.WS.B STI.WS.A DFS COF-P CMA TFG GS.PRJ GS.PRI STI GS.PRD CGBBW GS.PRC FITB GS.PRN GS.PRK COF.PRG WFCNP COF.PRH RF.PRB CMA.WS RF.PRA NTRSP WFC.PRL COF.PRP WFC.PRJ CMPWW DFS.PRB COF-D WFC.PRT GS COF-C DFS.PRBCL C.WS.B COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP STI.PRE C.PRU WFC.PRY COF.PRC WFC.PRX COF.PRD WFC.PRW WFC.PRV COF.PRF C.PRS WFC WFC.WS C.PRL C GSC GS.PRICL C.PRJ C.PRK COF C.PRG GSJ C.PRC HBAN CFG ALLY C.PRPCL GJS

55
Goldman says emerging markets are flashing green, buy local debt

7h theedgemarkets
TOKYO (June 21): Emerging market assets have been beaten up lately, but many of their fundamentals are still in good shape, and their local bonds are a buy, Goldman Sachs Group Inc strategists say.
JBK GS.PRICL GSC TFG GS.PRB GS.PRA GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC GJS GS.PRN GS.PRK

55
Goldman Says Emerging Markets Are Flashing Green, Buy Local Debt - Bloomberg

10h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK GS.PRICL GSC TFG GS.PRB GS.PRA GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC GJS GS.PRN GS.PRK

182
The Chinese Powerhouse That Scares Banks—and Wants to Make Them Customers - Bloomberg

10h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS GLSSP MS MGI JBK GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI BABA BLK MS.PRI GS.PRD MS.PRK 0700 GS.PRC GJS GS.PRN GS.PRK

95
Xiaomi Starts Taking Orders for the World’s Biggest IPO for Two Years - Bloomberg

11h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS GLSSP MS JBK CHLKF GSC GS.PRICL TFG GSJ 0941 GS.PRJ GS.PRI MS.PRI CHL GS.PRD MS.PRK GS.PRC GJS QCOM GS.PRN GS.PRK

95
Xiaomi Starts Taking Orders for Up to $6.1 Billion Hong Kong IPO

11h theedgemarkets
(June 21): Xiaomi Corp. started taking orders for the world’s biggest initial public offering in nearly two years, aiming to raise as much as $6.1 billion in Hong Kong.
GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS GLSSP MS JBK CHLKF GSC GS.PRICL TFG GSJ 0941 GS.PRJ GS.PRI MS.PRI CHL GS.PRD MS.PRK GS.PRC GJS QCOM GS.PRN GS.PRK

55
Goldman's David Solomon On Trade, China Business, Succession

16h valuewalk
David Solomon, president and chief operating officer at Goldman Sachs Group Inc., discusses trade friction between the United States and China, the firm’s business in China, how he views the U.S. economy, and succession plans at the firm. He speaks with Bloomberg’s Stephen Engle on “Bloomberg Surveillance.” (Source: Bloomberg)
JBK GS.PRICL GSC TFG GS.PRB GS.PRA GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC GJS GS.PRN GS.PRK

55
Goldman Sachs Is Considering Crypto Trades Beyond Futures, Solomon Says - Bloomberg

16h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK GS.PRICL GSC TFG GS.PRB GS.PRA GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC GJS GS.PRN GS.PRK

98
Solus Made Money From That CDS Litigation - Barron's

17h barrons
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
JBK BGX GSC HOVNP GS.PRICL TFG GS.PRB GS.PRA BX BGLF GSJ BGB GS.PRJ GS.PRI GS GLSSP HOVVB GS.PRD GS.PRC GJS GS.PRN HOV GS.PRK

78
Deere Legal Battle Highlights Race for $240 Billion Farm Tech Market - Bloomberg

17h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK GS.PRICL GSC TFG GS.PRB GS.PRA GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC MON GJS GS.PRN GS.PRK AGCO

55
Blankfein Cites a ‘Moral Imperative’ to Stop Separating Families - Bloomberg

19h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK GS.PRICL GSC TFG GS.PRB GS.PRA GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC GJS GS.PRN GS.PRK

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to GSC / GS Connect S&P GSCI Enhanced Community TR Strategy Index ETN due 5/8/2037 on message board site Silicon Investor.

Golden Star Resources Ltd. - A Potenial Ten Bagger GSCN - General Scanning
Geoscience Corp (GSCI)
CUSIP: 38144L852